Literature DB >> 17287899

Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis.

Hideaki Hamano1, Norikazu Arakura, Takashi Muraki, Yayoi Ozaki, Kendo Kiyosawa, Shigeyuki Kawa.   

Abstract

BACKGROUND: Autoimmune pancreatitis is a unique form of chronic pancreatitis characterized by high serum IgG4 concentrations and abundant IgG4-bearing plasma cell infiltration in the pancreatic lesion, and it has been reported to be associated with a variety of extrapancreatic lesions, leading us to postulate the concept of a systemic inflammatory disease. To confirm this, we clarified the exact distribution of these extrapancreatic lesions and provide a panoramic view of them.
METHODS: The frequency, distribution, clinical characteristics, and pathology of five extrapancreatic lesions were determined in 64 patients with autoimmune pancreatitis by examining clinical and laboratory findings.
RESULTS: The most frequent extrapancreatic lesion was hilar lymphadenopathy (80.4%), followed by extrapancreatic bile duct lesions (73.9%), lachrymal and salivary gland lesions (39.1%), hypothyroidism (22.2%), and retroperitoneal fibrosis (12.5%). No patients had all five types of lesions. Patients with hilar lymphadenopathy or lachrymal and salivary gland lesions were found to have significantly higher IgG4 levels than those without (P = 0.0042 and 0.0227, respectively). Patients with three lesions were found to have significantly higher IgG4 levels than those with no lesion, suggesting that patients with multiple extrapancreatic lesions have active disease. Similar to pancreatic lesions, extrapancreatic lesions have a characteristic histological finding of abundant IgG4-bearing plasma cell infiltration, and they respond favorably to corticosteroid therapy.
CONCLUSIONS: Autoimmune pancreatitis was recognized as a systemic inflammatory disease. Furthermore, recognition of these characteristic findings will aid in the correct diagnosis of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287899     DOI: 10.1007/s00535-006-1908-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  48 in total

1.  Autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis.

Authors:  Yoshihiko Fukukura; Fumito Fujiyoshi; Fumihiko Nakamura; Hiroyuki Hamada; Masayuki Nakajo
Journal:  AJR Am J Roentgenol       Date:  2003-10       Impact factor: 3.959

2.  Multiple pseudotumors in IgG4-associated multifocal systemic fibrosis.

Authors:  Hans J J van der Vliet; Roos M Perenboom
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

3.  Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome.

Authors:  M Yamamoto; S Harada; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; H Takahashi; K Imai
Journal:  Rheumatology (Oxford)       Date:  2004-10-27       Impact factor: 7.580

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

Review 5.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

6.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

7.  High-rate pulmonary involvement in autoimmune pancreatitis.

Authors:  K Hirano; T Kawabe; Y Komatsu; S Matsubara; O Togawa; T Arizumi; N Yamamoto; Y Nakai; N Sasahira; T Tsujino; N Toda; H Isayama; M Tada; M Omata
Journal:  Intern Med J       Date:  2006-01       Impact factor: 2.048

8.  Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.

Authors:  Takeshi Uehara; Hideaki Hamano; Shigeyuki Kawa; Kenji Sano; Takayuki Honda; Hiroyoshi Ota
Journal:  Pathol Int       Date:  2005-07       Impact factor: 2.534

9.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

10.  Ultrasonographic evaluation in patients with autoimmune-related pancreatitis.

Authors:  Naoko Hyodo; Takafumi Hyodo
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  82 in total

1.  Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Fumihiro Okumura; Katsuyuki Miyabe; Michihiro Yoshida; Hiroaki Yamashita; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2011-09-23       Impact factor: 7.527

Review 2.  The Clinical and Pathological Features of IgG(4)-Related Disease.

Authors:  Arezou Khosroshahi; Vikram Deshpande; John H Stone
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

3.  Conference report: Korea-Japan symposium on autoimmune pancreatitis.

Authors:  Seung Woo Park; Jae Bock Chung; Makoto Otsuki; Myung-Hwan Kim; Jae Hoon Lim; Shigeyuki Kawa; Tetsuhide Ito; Isao Nishimori; Ji Kon Ryu; Kazuichi Okazaki; Kyutaek Lee; Terumi Kamisawa
Journal:  Gut Liver       Date:  2008-09-30       Impact factor: 4.519

Review 4.  Autoimmune pancreatitis and IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Kensuke Takuma; Naoto Egawa; Koji Tsuruta; Tsuneo Sasaki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-15       Impact factor: 46.802

Review 5.  Autoimmune pancreatitis and IgG4-related systemic diseases.

Authors:  Lizhi Zhang; Thomas C Smyrk
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

6.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

Review 7.  Diagnosis of IgG4-related sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Itaru Naitoh; Kazuki Hayashi; Katsuyuki Miyabe; Shuya Simizu; Takashi Joh
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.

Authors:  Nao Fujimori; Tetsuhide Ito; Hisato Igarashi; Takamasa Oono; Taichi Nakamura; Yusuke Niina; Masayuki Hijioka; Lingaku Lee; Masahiko Uchida; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  An immunoglobulin G4-related sclerosing disease of the small bowel: CT and small bowel series findings.

Authors:  Younghwan Ko; Ji Young Woo; Jeong Won Kim; Hye Sook Hong; Ik Yang; Yul Lee; Daehyun Hwang; Seon Jeong Min
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

Review 10.  [IgG4-related disease].

Authors:  J Loock; B Manger
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.